Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Rothman

Showing results (171-180 of 262) with videos related to

Pageof 27
Sort By:
FEBS Letters|June 5, 1989
Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptorB R de Costa, L Band, R B Rothman, et al.
European Journal of Pharmacology|October 6, 1987
Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomographyR B Rothman, S McLean, V Bykov, et al.
Synapse (New York, N.Y.)|December 1, 1993
Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domainsQ Ni, H Xu, J S Partilla, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2000
Delta opioid binding selectivity of 3-ether analogs of naltrindoleA Coop, J Pinto, L Wang, et al.
Circulation|January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medicationsR B Rothman, M H Baumann, J E Savage, et al.
Neuropeptides|December 1, 1985
Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: optimization of assay conditionsR B Rothman, V Bykov, J A Danks, et al.
Journal of Medicinal Chemistry|April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligandsB R de Costa, R B Rothman, V Bykov, et al.
Molecular Pharmacology|November 9, 2006
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalizationC E Groer, K Tidgewell, R A Moyer, et al.
Peptides|January 1, 1993
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding siteR B Rothman, H Xu, G U Char, et al.
Brain Research. Developmental Brain Research|February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during developmentS McLean, R B Rothman, D M Chuang, et al.
Pageof 27

Showing results (171-180 of 262) with videos related to

Sort By:
Pageof 27
FEBS Letters|June 5, 1989
Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptorB R de Costa, L Band, R B Rothman, et al.
European Journal of Pharmacology|October 6, 1987
Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomographyR B Rothman, S McLean, V Bykov, et al.
Synapse (New York, N.Y.)|December 1, 1993
Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domainsQ Ni, H Xu, J S Partilla, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2000
Delta opioid binding selectivity of 3-ether analogs of naltrindoleA Coop, J Pinto, L Wang, et al.
Circulation|January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medicationsR B Rothman, M H Baumann, J E Savage, et al.
Neuropeptides|December 1, 1985
Preparation of rat brain membranes highly enriched with opiate kappa binding sites using site-directed acylating agents: optimization of assay conditionsR B Rothman, V Bykov, J A Danks, et al.
Journal of Medicinal Chemistry|April 1, 1990
Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligandsB R de Costa, R B Rothman, V Bykov, et al.
Molecular Pharmacology|November 9, 2006
An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalizationC E Groer, K Tidgewell, R A Moyer, et al.
Peptides|January 1, 1993
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding siteR B Rothman, H Xu, G U Char, et al.
Brain Research. Developmental Brain Research|February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during developmentS McLean, R B Rothman, D M Chuang, et al.
Pageof 27